238 related articles for article (PubMed ID: 33314123)
1. The role of neuraminidase in TLR4-MAPK signalling and the release of cytokines by lupus serum-stimulated mesangial cells.
Sundararaj K; Rodgers J; Angel P; Wolf B; Nowling TK
Immunology; 2021 Apr; 162(4):418-433. PubMed ID: 33314123
[TBL] [Abstract][Full Text] [Related]
2. The role of neuraminidase 1 (NEU1) in cytokine release by primary mouse mesangial cells and disease outcomes in murine lupus nephritis.
Rodgers J; Sundararaj K; Bruner E; Wolf B; Nowling TK
Autoimmunity; 2021 May; 54(3):163-175. PubMed ID: 33749450
[TBL] [Abstract][Full Text] [Related]
3. Neuraminidase activity mediates IL-6 production by activated lupus-prone mesangial cells.
Sundararaj K; Rodgers JI; Marimuthu S; Siskind LJ; Bruner E; Nowling TK
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F630-F642. PubMed ID: 29357434
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
Front Immunol; 2021; 12():584414. PubMed ID: 33717066
[TBL] [Abstract][Full Text] [Related]
5. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X
BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318
[TBL] [Abstract][Full Text] [Related]
6. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
7. Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells.
Lee SR; Rutan JA; Monteith AJ; Jones SZ; Kang SA; Krum KN; Kilmon MA; Roques JR; Wagner NJ; Clarke SH; Vilen BJ
J Immunol; 2012 Oct; 189(8):3859-68. PubMed ID: 22984080
[TBL] [Abstract][Full Text] [Related]
8. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
Zhai JX; Zhang ZX; Feng YJ; Ding SS; Wang XH; Zou LW; Ye DQ
Mol Biol Rep; 2012 Jun; 39(6):6763-71. PubMed ID: 22318546
[TBL] [Abstract][Full Text] [Related]
9. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
Nowling TK; Rodgers J; Thiyagarajan T; Wolf B; Bruner E; Sundararaj K; Molano I; Gilkeson G
PLoS One; 2020; 15(3):e0230499. PubMed ID: 32187230
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 Suppresses Mesangial Cell Proliferation and TGF-β1 Production via Inhibiting CXCR5-ERK Signaling Pathway in Lupus Nephritis.
Kong J; Li L; Lu Z; Song J; Yan J; Yang J; Gu Z; Da Z
Inflammation; 2019 Feb; 42(1):255-263. PubMed ID: 30209639
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of Toll-like Receptor 4.
Allendorf DH; Franssen EH; Brown GC
J Neurochem; 2020 Nov; 155(4):403-416. PubMed ID: 32279315
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK/Erk pathway in lupus nephritis.
Qi H; Xu L; Liu Q
Mol Med; 2023 Jul; 29(1):99. PubMed ID: 37488524
[TBL] [Abstract][Full Text] [Related]
17. Cytokine gene expression in the MRL/lpr model of lupus nephritis.
Lemay S; Mao C; Singh AK
Kidney Int; 1996 Jul; 50(1):85-93. PubMed ID: 8807576
[TBL] [Abstract][Full Text] [Related]
18. Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.
Richard EM; Thiyagarajan T; Bunni MA; Basher F; Roddy PO; Siskind LJ; Nietert PJ; Nowling TK
PLoS One; 2013; 8(9):e75175. PubMed ID: 24040398
[TBL] [Abstract][Full Text] [Related]
19. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4
Dai R; Heid B; Xu X; Xie H; Reilly CM; Ahmed SA
BMC Immunol; 2020 Jul; 21(1):41. PubMed ID: 32646370
[TBL] [Abstract][Full Text] [Related]
20. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
